The amendment cuts the number of COVID-19 vaccines that the EU must buy and pushes the delivery deadline to 2026.

The U.S. Food and Drug Administration on Thursday granted a full approval to Pfizer’s Paxlovid, an oral antiviral COVID-19 treatment for adults at high risk of progression to severe disease.

Germany’s BioNTech said it was on track to introduce a COVID-19 shot by the early fall in the northern hemisphere that is adapted to currently dominant virus variants in line with recommendations by the World Health Organization.

The company said it filed a counterclaim alleging that Pfizer and its German partner BioNTech infringed on nine of its patents, broader than its original claim of three patents.

The European Union and the United States have launched a new joint health task force to cooperate on cancer, global health threats and related supply chains and infrastructure, officials told a press conference today.

The company’s Branchburg, New Jersey location is the home of its largest diagnostic operations center in the United States.

“The end of the COVID-19 public health emergency marks a tremendous transition for our country, for public health, and in my tenure as CDC Director,” Walensky wrote to President Joe Biden in her resignation letter.

A panel of global health experts will meet on Thursday to decide if COVID-19 is still an emergency under the World Health Organization’s rules, a status that helps maintain international focus on the pandemic.

The World Health Organization officially launched its mRNA vaccine technology hub in Cape Town, a facility established during the COVID-19 pandemic to help poorer countries struggling to gain access to life-saving medication.

Pending more positive data and regulatory approval, the company plans to make the antibody available by the end of 2023.